financetom
Business
financetom
/
Business
/
Paul Weiss adds antitrust trio from rival law firm A&O Shearman
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paul Weiss adds antitrust trio from rival law firm A&O Shearman
Sep 15, 2025 6:23 PM

Sept 15 (Reuters) - Prominent Wall Street law firm Paul

Weiss has added three partners to its antitrust team, including

the head of rival A&O Shearman's global antitrust practice,

after several high profile lawyer departures in the spring.

Paul Weiss on Monday said it hired David Higbee, who led A&O

Shearman's antitrust group and was a member of it's executive

committee, along with the firm's partners Ben Gris and Djordje

Petkoski.

Paul Weiss chairman Brad Karp in a statement said the

Washington-based trio would strengthen the firm's antitrust

capabilities.

Higbee told Reuters he was not looking to leave A&O

Shearman, but the move was an opportunity he did not want to

pass up.

A Paul Weiss spokesperson did not immediately respond to

requests for comment.

A&O Shearman in a statement thanked the lawyers for their

time there.

The moves follow the departures in May of a core team of

Paul Weiss litigators with antitrust expertise, including Karen

Dunn, William Isaacson and Jeannie Rhee.

Their firm Dunn Isaacson Rhee has since grown with

additional hires from Paul Weiss and other firms.

Dunn was co-chair of Paul Weiss's litigation department and

is a leading Washington lawyer. Dunn's new firm has said its

clients include Amazon ( AMZN ), Warner Bros. Discovery ( WBD ), Qualcomm ( QCOM ) and

Google.

Paul Weiss in March struck a deal with President Donald

Trump to avoid an executive order by the Republican leader

targeting the firm over its past hires and its diversity

policies.

Eight other major firms followed Paul Weiss' lead, pledging

nearly $1 billion in free legal work to causes Trump supports.

Paul Weiss has defended its deal, asserting that it was

necessary to protect the firm. Dunn, Isaacson, and Rhee have not

cited Paul Weiss' deal with Trump as a reason for leaving the

firm.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Most U.S. LNG exports head to Europe amidst cold weather and strong prices
Most U.S. LNG exports head to Europe amidst cold weather and strong prices
Mar 3, 2025
* Most U.S. LNG exports in February went to Europe * European prices remain elevated, attracting U.S. exports * U.S. begins to benefit from Plaquemines LNG export plant startup * By Curtis Williams HOUSTON, March 3 (Reuters) - Europe soaked up most U.S. liquefied natural gas (LNG) exports for the second straight month in February, as cold weather and strong...
Best Buy Q4 Likely Solid but Outlook Muted, Wedbush Says
Best Buy Q4 Likely Solid but Outlook Muted, Wedbush Says
Mar 3, 2025
11:48 AM EST, 03/03/2025 (MT Newswires) -- Best Buy ( BBY ) is set for solid Q4 earnings March 4, but its 2025 guidance could be soft, Wedbush said in a Monday note. We expect a good quarter on the back of a favorable holiday shopping season and conservative guidance, the report said. But we expect soft 2025 guidance given...
Montrose Secures Role In $1.5 Billion Air Force Environmental Contract: Details
Montrose Secures Role In $1.5 Billion Air Force Environmental Contract: Details
Mar 3, 2025
Montrose Environmental Group ( MEG ) has been selected by the U.S. Air Force for a $1.5 billion Multiple Award Task Order Contract (MATOC) to support global environmental projects. In partnership with Tanaq Environmental —an Alaska Native Corporation and small disadvantaged business—Montrose will focus on contaminant remediation, including PFAS, as well as environmental planning and support services over the next...
Eton Pharmaceuticals Launches Galzin Capsules for Wilson Disease Treatment
Eton Pharmaceuticals Launches Galzin Capsules for Wilson Disease Treatment
Mar 3, 2025
11:47 AM EST, 03/03/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Monday that it has officially launched Galzin, which is approved by the US Food and Drug Administration for the maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent. The company said Galzin capsules are exclusively available through specialty pharmacy Optime...
Copyright 2023-2026 - www.financetom.com All Rights Reserved